Promising Advances in Parkinson’s Disease Dementia Treatment by Anavex Life Sciences
OnAnavex Life Sciences has recently unveiled promising findings from a phase 2 extension study concerning its investigational drug ANAVEX2-73, also known as blarcamesine. Conducted.
Read More